These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28881785)

  • 21. Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation.
    Wen S; Liu Y; Yang M; Yang K; Huang J; Feng D
    Oncol Rep; 2016 Oct; 36(4):2193-9. PubMed ID: 27509921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-199a/b-5p inhibits hepatocellular carcinoma progression by post-transcriptionally suppressing ROCK1.
    Zhan Y; Zheng N; Teng F; Bao L; Liu F; Zhang M; Guo M; Guo W; Ding G; Wang Q
    Oncotarget; 2017 Sep; 8(40):67169-67180. PubMed ID: 28978024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma].
    Yang H; Zheng W; Zhao W; Guan C; An J
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):804-11. PubMed ID: 23803188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
    Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S
    Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
    Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
    Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway.
    Yang F; Yin Y; Wang F; Wang Y; Zhang L; Tang Y; Sun S
    Hepatology; 2010 May; 51(5):1614-23. PubMed ID: 20209605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
    Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
    Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7.
    Yang W; Dou C; Wang Y; Jia Y; Li C; Zheng X; Tu K
    Oncol Rep; 2015 Nov; 34(5):2576-84. PubMed ID: 26323375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-129-5p inhibits hepatocellular carcinoma cell metastasis and invasion via targeting ETS1.
    Ma N; Chen F; Shen SL; Chen W; Chen LZ; Su Q; Zhang LJ; Bi J; Zeng WT; Li W; Huang XH; Wang Q
    Biochem Biophys Res Commun; 2015 Jun; 461(4):618-23. PubMed ID: 25912876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.
    Cao L; Xie B; Yang X; Liang H; Jiang X; Zhang D; Xue P; Chen D; Shao Z
    PLoS One; 2015; 10(7):e0133074. PubMed ID: 26177288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NEK2 regulates stem-like properties and predicts poor prognosis in hepatocellular carcinoma.
    Lin S; Zhou S; Jiang S; Liu X; Wang Y; Zheng X; Zhou H; Li X; Cai X
    Oncol Rep; 2016 Aug; 36(2):853-62. PubMed ID: 27349376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
    El Tayebi HM; Hosny KA; Esmat G; Breuhahn K; Abdelaziz AI
    FEBS Lett; 2012 Sep; 586(19):3309-16. PubMed ID: 22819824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma.
    Chen Y; Chen J; Liu Y; Li S; Huang P
    Med Sci Monit; 2015 Jun; 21():1864-71. PubMed ID: 26119771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-195-5p acts as an anti-oncogene by targeting PHF19 in hepatocellular carcinoma.
    Xu H; Hu YW; Zhao JY; Hu XM; Li SF; Wang YC; Gao JJ; Sha YH; Kang CM; Lin L; Huang C; Zhao JJ; Zheng L; Wang Q
    Oncol Rep; 2015 Jul; 34(1):175-82. PubMed ID: 25955388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].
    Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1.
    Dou C; Wang Y; Li C; Liu Z; Jia Y; Li Q; Yang W; Yao Y; Liu Q; Tu K
    Oncotarget; 2015 May; 6(15):13216-28. PubMed ID: 25965836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of miR-485-5p in hepatocellular carcinoma progression targeting EMMPRIN.
    Sun X; Liu Y; Li M; Wang M; Wang Y
    Biomed Pharmacother; 2015 May; 72():58-65. PubMed ID: 26054676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo.
    Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C
    Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.